Statistics for Altimmune (id:6652 ALT)

Valuation metrics

Market cap

508.54M

Enterprise value

403.65M

Trailing P/E (ttm)

-5.23

Forward P/E

-4.86

PEG ratio

-4.86

Price/Sales (ttm)

9.78K

Price/Book (mrq)

3.81

Enterprise Value/Revenue

7.76K

Enterprise Value/EBITDA

-4.07

Overview

Shares outstanding

71.12M

Float

70.60M

Shares short

22.94M

% Held by insiders

0.01%

% Held by institutions

0.57%

Average volume (10 days)

5.90M

Average volume (90 days)

Price summary

52-Week low

2.76

52-Week high

14.84

52-Week change

64.75%

Beta

0.07

50-Day moving average

7.02

200-Day moving average

7.63

Dividends and splits

Forward annual dividend rate

11.64

Forward annual dividend yield

1.34

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

September 14th, 2018

Ex-dividend date

January 20th, 2017

Last split factor

2:1

Last split date

September 14th, 2018

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-495,340.00%

Operational effectiveness

Return on assets

-39.56%

Return on equity

-72.96%

Income statement

Revenue (ttm)

0.00

Revenue per share (ttm)

0.00

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-99,191,000.00

Net income to common (ttm)

-103,520,000.00

Diluted EPS (ttm)

-1.63

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

139.38M

Total cash per share (mrq)

1.96

Total debt (mrq)

1.77M

Total Debt/Equity (mrq)

1.33

Current ratio (mrq)

1.69K%

Book value per share (mrq)

1.88

Cash flow

Cash flow statement

-78,116,000.00

Levered free cash flow (LFCF)

-45,628,000.00